U.S. Army Medical Research & Development Command
investment firm
About
USAMRMC is conducts research to deliver the medical solutions to enhance, protect and treat the warfighter.
Highlights
Details
- Founded date
- Nov 3, 1994
- Operating Status
- Active
- Legal Name
- U.S. Army Medical Research & Development Command
Investments
Number of Investments
Number of Lead Investments
7
6
U.S. Army Medical Research & Development Command has made 7 investments. Their most recent investment was on
May 26, 2021, when Inhalon Biopharma raised $7M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 26, 2021
Inhalon Biopharma
|
Grant | $7M | Biopharma | Yes |
|
May 18, 2021
Oculogica
|
Grant | $2M | Health Care | Yes |
|
Sep 24, 2020
Lumen Bioscience
|
Grant | $4M | Biopharma | Yes |
|
Feb 19, 2018
Medcura
|
Grant | $1.40M | Health Care | Yes |
|
Aug 14, 2017
Cytosorbents
|
Grant | $719K | Biotechnology | Yes |
Exits
U.S. Army Medical Research & Development Command has had 3 exits. U.S. Army Medical Research & Development Command most notable exits include SmartCells , Cytosorbents
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Dec 2, 2010 | SmartCells | M&A | Biotechnology | Detail |
| Aug 18, 2006 | Cytosorbents | IPO | Biotechnology | Detail |
| Feb 20, 1998 | Lexicon Pharmaceuticals | IPO | Bioinformatics | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
